Funding for this research was provided by:
Big Health Inc. (N/A)
Received: 7 October 2019
Accepted: 4 March 2020
First Online: 23 April 2020
Ethics approval and consent to participate
: This study has been granted ethical approval by the University of Oxford Central University Research Ethics Committee (CUREC; reference number R61262/RE002). Informed consent will be obtained from all participants through completion of an online consent form. Important modifications to the trial protocol will be submitted for approval from the trial sponsor (University of Oxford; ExternalRef removed) and CUREC.
: Not applicable.
: CAE is co-founder and Chief Medical Officer of Big Health Inc., and is a shareholder in the company. CBM, ALH, RS, MLD and JC are employed by Big Health Inc., and are salaried by the company. JG previously received a salary from Big Health Inc. JAJS is a paid Clinical Advisor for Big Health Inc., and receives royalty payments from Oxford University Press and Academic Press. The remaining authors declare that they have no competing interests.